Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2

Four longitudinal studies of vestibular schwannoma (VS) growth rates in neurofibromatosis 2 (NF2) have yielded very different results on the relationship of VS growth rates to age. The studies had different patient eligibility criteria, indices of VS growth rates, VS volumetric methods, and sample sizes. We reanalysed data from two of the longitudinal studies and used data from the population based United Kingdom NF2 Registry to determine the most likely reason for the different results and the actual relationship of VS growth rates to age. We found that the eligibility criterion in one study caused selection bias for slower growing VS. The proper interpretation of the results from the four studies is that VS growth rates in NF2 are highly variable but tend to decrease with increasing age. Clinical trials for VS in NF2 should focus on younger patients because VS growth rates tend to decrease with increasing age, and because faster growing VS are more likely to be excised with increasing age than slower growing VS.

[1]  L. Fisher,et al.  Vestibular Schwannoma Growth Rates in Neurofibromatosis Type 2 Natural History Consortium Subjects , 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[2]  D. Evans,et al.  Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study. , 2004, American journal of human genetics.

[3]  E. Laasonen,et al.  Volume growth rate of acoustic neurinomas , 2004, Neuroradiology.

[4]  D. Evans,et al.  Predictors of the risk of mortality in neurofibromatosis 2. , 2002, American journal of human genetics.

[5]  E. Makariou,et al.  Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2. , 2002, Journal of neurosurgery.

[6]  L. Kluwe,et al.  Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study. , 2002, Journal of neurosurgery.

[7]  S. Nutik,et al.  Determinants of tumor size and growth in vestibular schwannomas. , 2001, Journal of neurosurgery.

[8]  E. Makariou,et al.  Growth Rate Characteristics of Acoustic Neuromas Associated With Neurofibromatosis Type 2 , 1996, The Laryngoscope.

[9]  S. Pulst,et al.  The neuroimaging and clinical spectrum of neurofibromatosis 2. , 1996, Neurosurgery.

[10]  H. Haapasalo,et al.  Proliferative Potential of Sporadic and Neurofibromatosis 2-Associated Schwannomas as Studied by MIB-1 (Ki-67) and PCNA Labeling , 1995, Journal of neuropathology and experimental neurology.

[11]  M I Kaiser-Kupfer,et al.  Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. , 1994, American journal of medical genetics.

[12]  H. Silverstein,et al.  A Comparison of Growth Rates of Acoustic Neuromas: Nonsurgical Patients vs. Subtotal Resection , 1993, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[13]  R. Sobel,et al.  Vestibular (Acoustic) Schwannomas: Histologic Features in Neurofibromatosis 2 and in Unilateral Cases , 1993, Journal of neuropathology and experimental neurology.

[14]  D. Evans,et al.  A clinical study of type 2 neurofibromatosis. , 1992, The Quarterly journal of medicine.

[15]  J. Kanzaki,et al.  The growth rate of acoustic neuromas. , 1991, Acta oto-laryngologica. Supplementum.